SCIE期刊CURRENT CANCER DRUG TARGETS 2024/2025影響因子:2.326 (CURR CANCER DRUG TAR) (1568-0096). (ONCOLOGY)(腫瘤學(xué))Science Citati

enflame

Submitted on: 28 February 2000. Revised on: 10 June 2000. Accepted on: 19 July 2000. ___________________CURRENT CANCER DRUG TARGETS---BENTHAM SCIENCE PUBL LTD

podiatrist

Submitted on: 12 April 2020. Revised on: 22 July 2020. Accepted on: 14 August 2020. ___________________CURRENT CANCER DRUG TARGETS---BENTHAM SCIENCE PUBL LTD

原告

Submitted on: 19 August 2009. Revised on: 09 September 2009. Accepted on: 27 September 2009. ___________________CURRENT CANCER DRUG TARGETS---BENTHAM SCIENCE PUBL LTD

Embolic-Stroke

Cholesterol

Submitted on: 08 December 2015. Revised on: 25 March 2016. Accepted on: 15 April 2016. ___________________CURRENT CANCER DRUG TARGETS---BENTHAM SCIENCE PUBL LTD

忙碌

織物

Submitted on: 30 June 2004. Revised on: 19 October 2004. Accepted on: 19 November 2004. ___________________CURRENT CANCER DRUG TARGETS---BENTHAM SCIENCE PUBL LTD

AGGER

Submitted on: 14 October 2002. Revised on: 15 January 2003. Accepted on: 21 February 2003. ___________________CURRENT CANCER DRUG TARGETS---BENTHAM SCIENCE PUBL LTD

愉快么

Submitted on: 22 April 2014. Revised on: 15 August 2014. Accepted on: 09 September 2014. ___________________CURRENT CANCER DRUG TARGETS---BENTHAM SCIENCE PUBL LTD

起草

Submitted on: 16 October 2004. Revised on: 06 November 2004. Accepted on: 18 November 2004. ___________________CURRENT CANCER DRUG TARGETS---BENTHAM SCIENCE PUBL LTD